Hanno Reinhard Hock, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2022 | 1539 | 0.890 |
Why?
|
| Hematopoietic Stem Cells | 9 | 2010 | 3390 | 0.790 |
Why?
|
| Repressor Proteins | 6 | 2017 | 2982 | 0.680 |
Why?
|
| Anemia, Aplastic | 1 | 2021 | 228 | 0.670 |
Why?
|
| Philadelphia Chromosome | 1 | 2020 | 117 | 0.670 |
Why?
|
| Proto-Oncogene Proteins c-ets | 3 | 2017 | 311 | 0.600 |
Why?
|
| Hematopoiesis | 3 | 2017 | 2063 | 0.560 |
Why?
|
| Oncogene Proteins, Fusion | 5 | 2022 | 1596 | 0.540 |
Why?
|
| DNA-Binding Proteins | 6 | 2012 | 9591 | 0.420 |
Why?
|
| Transcription Factors | 7 | 2012 | 12102 | 0.400 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 1 | 2012 | 164 | 0.370 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2012 | 2802 | 0.370 |
Why?
|
| Growth and Development | 1 | 2010 | 47 | 0.360 |
Why?
|
| Embryonic Development | 2 | 2012 | 716 | 0.350 |
Why?
|
| Histones | 4 | 2019 | 2582 | 0.330 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2018 | 4496 | 0.320 |
Why?
|
| Leukemia | 1 | 2017 | 1523 | 0.320 |
Why?
|
| Pluripotent Stem Cells | 2 | 2012 | 792 | 0.300 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2012 | 679 | 0.290 |
Why?
|
| Lymphocytes | 2 | 2006 | 2611 | 0.290 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2009 | 352 | 0.280 |
Why?
|
| Leukemia, Myeloid, Acute | 4 | 2020 | 3610 | 0.280 |
Why?
|
| Cell Differentiation | 10 | 2018 | 11481 | 0.270 |
Why?
|
| Bone Marrow Cells | 3 | 2009 | 2414 | 0.270 |
Why?
|
| Nuclear Proteins | 2 | 2012 | 5795 | 0.270 |
Why?
|
| Myelopoiesis | 2 | 2006 | 134 | 0.260 |
Why?
|
| Green Fluorescent Proteins | 3 | 2012 | 2057 | 0.250 |
Why?
|
| Cell Lineage | 4 | 2019 | 2532 | 0.240 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2022 | 2505 | 0.240 |
Why?
|
| Erythrocytes | 1 | 2014 | 2415 | 0.240 |
Why?
|
| Hepatocyte Growth Factor | 2 | 2018 | 267 | 0.230 |
Why?
|
| Neutrophils | 3 | 2010 | 3767 | 0.230 |
Why?
|
| Bone Marrow | 1 | 2014 | 2914 | 0.220 |
Why?
|
| Oncogenes | 1 | 2009 | 1220 | 0.220 |
Why?
|
| Blood Platelets | 1 | 2014 | 2519 | 0.220 |
Why?
|
| Bone Marrow Examination | 1 | 2021 | 155 | 0.190 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 2022 | 158 | 0.190 |
Why?
|
| Sickle Cell Trait | 1 | 2021 | 85 | 0.190 |
Why?
|
| Lysine | 2 | 2019 | 1001 | 0.190 |
Why?
|
| Epistaxis | 1 | 2021 | 111 | 0.180 |
Why?
|
| Purpura | 1 | 2021 | 116 | 0.180 |
Why?
|
| Oropharynx | 1 | 2021 | 133 | 0.180 |
Why?
|
| Myeloid Cells | 1 | 2005 | 821 | 0.180 |
Why?
|
| Blast Crisis | 1 | 2020 | 101 | 0.170 |
Why?
|
| Pharyngitis | 1 | 2021 | 220 | 0.170 |
Why?
|
| Leukemia, T-Cell | 1 | 2019 | 101 | 0.170 |
Why?
|
| Chromatin | 1 | 2010 | 2938 | 0.160 |
Why?
|
| Gene Expression Regulation | 2 | 2014 | 11902 | 0.160 |
Why?
|
| Azepines | 1 | 2019 | 330 | 0.150 |
Why?
|
| Pyrimidines | 2 | 2020 | 3016 | 0.150 |
Why?
|
| Antigens, CD19 | 1 | 2020 | 424 | 0.140 |
Why?
|
| Methionine | 1 | 2019 | 569 | 0.140 |
Why?
|
| Mice | 18 | 2019 | 81209 | 0.140 |
Why?
|
| Teratoma | 1 | 2019 | 403 | 0.140 |
Why?
|
| Bromodeoxyuridine | 2 | 2008 | 311 | 0.140 |
Why?
|
| Zinc Fingers | 2 | 2012 | 568 | 0.130 |
Why?
|
| DNA Primers | 2 | 2014 | 2818 | 0.130 |
Why?
|
| Multipotent Stem Cells | 2 | 2010 | 200 | 0.130 |
Why?
|
| Animals | 21 | 2019 | 167960 | 0.130 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2020 | 685 | 0.130 |
Why?
|
| Antifungal Agents | 1 | 2020 | 749 | 0.120 |
Why?
|
| Cell Survival | 1 | 2004 | 5797 | 0.120 |
Why?
|
| B-Lymphocytes | 3 | 2018 | 4742 | 0.110 |
Why?
|
| Methylation | 2 | 2019 | 1081 | 0.110 |
Why?
|
| Stem Cell Transplantation | 1 | 2021 | 1601 | 0.110 |
Why?
|
| Flow Cytometry | 3 | 2014 | 5869 | 0.100 |
Why?
|
| Recurrence | 2 | 2022 | 8483 | 0.100 |
Why?
|
| Paneth Cells | 1 | 2012 | 98 | 0.100 |
Why?
|
| Immunoconjugates | 1 | 2019 | 949 | 0.100 |
Why?
|
| Embryoid Bodies | 1 | 2012 | 65 | 0.100 |
Why?
|
| Lymphopoiesis | 2 | 2010 | 133 | 0.100 |
Why?
|
| Microarray Analysis | 1 | 2014 | 747 | 0.090 |
Why?
|
| Cell Cycle | 3 | 2010 | 2935 | 0.090 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2020 | 1455 | 0.090 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2012 | 277 | 0.090 |
Why?
|
| Receptors, Cell Surface | 2 | 2010 | 2825 | 0.090 |
Why?
|
| Mutagenesis | 1 | 2014 | 1234 | 0.090 |
Why?
|
| Cyclin E | 1 | 2010 | 155 | 0.090 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2022 | 11713 | 0.090 |
Why?
|
| Receptor, Anaphylatoxin C5a | 1 | 2010 | 87 | 0.090 |
Why?
|
| Core Binding Factors | 1 | 2009 | 29 | 0.080 |
Why?
|
| Pyrazoles | 1 | 2020 | 1999 | 0.080 |
Why?
|
| Oncogene Fusion | 1 | 2009 | 81 | 0.080 |
Why?
|
| Transplantation, Homologous | 1 | 2017 | 4815 | 0.080 |
Why?
|
| Antigens, CD | 2 | 2010 | 4000 | 0.080 |
Why?
|
| Interleukin-7 | 1 | 2009 | 142 | 0.080 |
Why?
|
| Germ-Line Mutation | 1 | 2017 | 1842 | 0.080 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 1 | 2010 | 377 | 0.080 |
Why?
|
| Cell Movement | 2 | 2018 | 5206 | 0.080 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2012 | 633 | 0.070 |
Why?
|
| Cytarabine | 2 | 2019 | 696 | 0.070 |
Why?
|
| Cell Proliferation | 3 | 2012 | 10442 | 0.070 |
Why?
|
| Mice, Transgenic | 3 | 2019 | 9530 | 0.070 |
Why?
|
| Gene Knockout Techniques | 1 | 2010 | 802 | 0.070 |
Why?
|
| Bone Marrow Transplantation | 3 | 2019 | 2693 | 0.070 |
Why?
|
| Humans | 18 | 2022 | 760613 | 0.070 |
Why?
|
| Immunophenotyping | 2 | 2018 | 1870 | 0.070 |
Why?
|
| Genetic Vectors | 2 | 2014 | 3380 | 0.070 |
Why?
|
| Microscopy, Fluorescence | 1 | 2014 | 2651 | 0.070 |
Why?
|
| Embryonic Stem Cells | 1 | 2014 | 1262 | 0.070 |
Why?
|
| Receptors, IgG | 1 | 2010 | 558 | 0.070 |
Why?
|
| Base Sequence | 2 | 2010 | 12444 | 0.070 |
Why?
|
| Intestine, Small | 1 | 2012 | 1207 | 0.070 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 3759 | 0.070 |
Why?
|
| Diagnosis, Differential | 1 | 2021 | 12968 | 0.070 |
Why?
|
| Transcription Factor AP-1 | 1 | 2007 | 321 | 0.070 |
Why?
|
| Immunotherapy | 1 | 2022 | 4642 | 0.070 |
Why?
|
| Mammary Glands, Animal | 1 | 2007 | 271 | 0.070 |
Why?
|
| Mice, Knockout | 5 | 2018 | 14374 | 0.070 |
Why?
|
| Gene Targeting | 1 | 2009 | 839 | 0.060 |
Why?
|
| Multiprotein Complexes | 1 | 2012 | 1120 | 0.060 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2017 | 5659 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 1 | 2012 | 3800 | 0.060 |
Why?
|
| Colon | 1 | 2012 | 1788 | 0.060 |
Why?
|
| Genome | 1 | 2012 | 1739 | 0.060 |
Why?
|
| HeLa Cells | 1 | 2010 | 3105 | 0.060 |
Why?
|
| Young Adult | 5 | 2021 | 58748 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2012 | 3734 | 0.060 |
Why?
|
| Neoplasms | 2 | 2010 | 22075 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 6544 | 0.050 |
Why?
|
| Male | 10 | 2022 | 359718 | 0.050 |
Why?
|
| Respiratory Burst | 1 | 2003 | 110 | 0.050 |
Why?
|
| Models, Animal | 1 | 2009 | 2117 | 0.050 |
Why?
|
| Longevity | 1 | 2010 | 1050 | 0.050 |
Why?
|
| Cell Division | 3 | 2004 | 4463 | 0.050 |
Why?
|
| Hepatocytes | 1 | 2009 | 1229 | 0.050 |
Why?
|
| Stem Cells | 2 | 2012 | 3524 | 0.050 |
Why?
|
| Genes, ras | 1 | 2004 | 654 | 0.050 |
Why?
|
| Molecular Sequence Data | 2 | 2010 | 17624 | 0.040 |
Why?
|
| Boron Compounds | 1 | 2022 | 180 | 0.040 |
Why?
|
| Idarubicin | 1 | 2019 | 59 | 0.040 |
Why?
|
| Protein Binding | 1 | 2012 | 9335 | 0.040 |
Why?
|
| Mitoxantrone | 1 | 2019 | 149 | 0.040 |
Why?
|
| Neoplastic Stem Cells | 1 | 2007 | 1347 | 0.040 |
Why?
|
| Vincristine | 1 | 2022 | 1038 | 0.040 |
Why?
|
| Congenital Abnormalities | 1 | 2004 | 704 | 0.040 |
Why?
|
| Glycine | 1 | 2022 | 662 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2010 | 13451 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2012 | 7593 | 0.040 |
Why?
|
| Etoposide | 1 | 2019 | 630 | 0.040 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2007 | 2829 | 0.040 |
Why?
|
| Fibroblasts | 2 | 2009 | 4089 | 0.040 |
Why?
|
| Erythroid Cells | 1 | 2019 | 235 | 0.040 |
Why?
|
| Growth Disorders | 1 | 2003 | 653 | 0.040 |
Why?
|
| Doxycycline | 1 | 2019 | 341 | 0.040 |
Why?
|
| Granulocytes | 1 | 2019 | 551 | 0.040 |
Why?
|
| Maximum Tolerated Dose | 1 | 2019 | 877 | 0.040 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2009 | 3604 | 0.040 |
Why?
|
| Phagocytosis | 1 | 2003 | 1535 | 0.030 |
Why?
|
| Pregnancy | 2 | 2017 | 29746 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2004 | 2668 | 0.030 |
Why?
|
| Models, Theoretical | 1 | 2008 | 3562 | 0.030 |
Why?
|
| Remission Induction | 1 | 2022 | 2392 | 0.030 |
Why?
|
| Survival Rate | 1 | 2010 | 12810 | 0.030 |
Why?
|
| Bacterial Infections | 1 | 2003 | 1403 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2018 | 2471 | 0.030 |
Why?
|
| T-Lymphocytes | 2 | 2019 | 10181 | 0.030 |
Why?
|
| Integrases | 2 | 2007 | 516 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 1792 | 0.030 |
Why?
|
| Adult | 4 | 2020 | 220007 | 0.030 |
Why?
|
| Spleen | 1 | 2018 | 2298 | 0.030 |
Why?
|
| Female | 8 | 2020 | 391246 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2019 | 4899 | 0.020 |
Why?
|
| Aged | 5 | 2022 | 169143 | 0.020 |
Why?
|
| Interleukin-1alpha | 1 | 2010 | 86 | 0.020 |
Why?
|
| Disease Management | 1 | 2020 | 2514 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2004 | 22020 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2019 | 6831 | 0.020 |
Why?
|
| Chemotaxis | 1 | 2012 | 598 | 0.020 |
Why?
|
| Leukotrienes | 1 | 2010 | 231 | 0.020 |
Why?
|
| Chimera | 1 | 2009 | 453 | 0.020 |
Why?
|
| Macrophages | 1 | 2003 | 5745 | 0.020 |
Why?
|
| Arthritis, Experimental | 1 | 2010 | 291 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2018 | 5496 | 0.020 |
Why?
|
| Nervous System Diseases | 1 | 2017 | 1647 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2007 | 285 | 0.020 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2007 | 124 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2019 | 10185 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 2009 | 897 | 0.020 |
Why?
|
| Lentivirus | 1 | 2009 | 506 | 0.020 |
Why?
|
| Models, Biological | 1 | 2003 | 9468 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2012 | 3602 | 0.020 |
Why?
|
| Penetrance | 1 | 2007 | 388 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2009 | 1529 | 0.020 |
Why?
|
| Middle Aged | 4 | 2020 | 220359 | 0.020 |
Why?
|
| Genes, Dominant | 1 | 2007 | 863 | 0.020 |
Why?
|
| Protein Kinases | 1 | 2012 | 1612 | 0.020 |
Why?
|
| Phenotype | 1 | 2003 | 16548 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2019 | 5251 | 0.010 |
Why?
|
| Actins | 1 | 2012 | 2049 | 0.010 |
Why?
|
| Multigene Family | 1 | 2007 | 1077 | 0.010 |
Why?
|
| Parity | 1 | 2007 | 925 | 0.010 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2004 | 84 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2022 | 64981 | 0.010 |
Why?
|
| Interleukin-1beta | 1 | 2010 | 999 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2009 | 2671 | 0.010 |
Why?
|
| Brain | 1 | 2010 | 26951 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 2004 | 751 | 0.010 |
Why?
|
| Incidence | 1 | 2020 | 21391 | 0.010 |
Why?
|
| Risk Factors | 2 | 2019 | 74333 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2012 | 2896 | 0.010 |
Why?
|
| Autoantibodies | 1 | 2010 | 2119 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2004 | 698 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 18137 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2007 | 21029 | 0.010 |
Why?
|
| Mutation | 2 | 2019 | 29957 | 0.010 |
Why?
|
| DNA | 1 | 2012 | 7233 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2004 | 1674 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 39262 | 0.010 |
Why?
|
| Autoimmune Diseases | 1 | 2010 | 2250 | 0.010 |
Why?
|
| Viral Proteins | 1 | 2004 | 1802 | 0.010 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2003 | 1137 | 0.010 |
Why?
|
| Alleles | 1 | 2007 | 6900 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2019 | 23374 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2007 | 3663 | 0.010 |
Why?
|
| Cell Line | 1 | 2009 | 15620 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 58980 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2009 | 18955 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2004 | 2924 | 0.010 |
Why?
|
| Adolescent | 1 | 2017 | 87809 | 0.010 |
Why?
|